StockData
GE HealthCare Technologies Inc. logo

GE HealthCare Technologies Inc. (GEHC) stock

GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 15/3011% below fair value
$81.84−1.12 (-1.35%)

Close on Nov 17, 2026Market cap $37.00BP/E 17.3Yield 0.17%

GE HealthCare Technologies r&d expenses

Research and development expenses are spending on new products and technology.

GE HealthCare Technologies's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.31B, up 2.3% year over year. For fiscal 2025 it was $1.26B, down 3.9% from the year before. The highest annual figure on record is $1.31B in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.26B-3.9%
FY2024Dec 31, 2024$1.31B+8.8%
FY2023Dec 31, 2023$1.21B+17.4%
FY2022Dec 31, 2022$1.03B+25.7%
FY2021Dec 31, 2021$816.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$320.00M+9.6%
Q2 FY2026Jun 30, 2026$323.00M+7.0%
Q1 FY2026Mar 31, 2026$345.00M+0.3%
Q4 FY2025Dec 31, 2025$323.00M-6.1%
Q3 FY2025Sep 30, 2025$292.00M-7.6%
Q2 FY2025Jun 30, 2025$302.00M-7.6%
Q1 FY2025Mar 31, 2025$344.00M+6.2%
Q4 FY2024Dec 31, 2024$344.00M+9.2%
Q3 FY2024Sep 30, 2024$316.00M-1.9%
Q2 FY2024Jun 30, 2024$327.00M+9.7%
Q1 FY2024Mar 31, 2024$324.00M+20.0%
Q4 FY2023Dec 31, 2023$315.00M+16.2%
Q3 FY2023Sep 30, 2023$322.00M+23.8%
Q2 FY2023Jun 30, 2023$298.00M+16.0%
Q1 FY2023Mar 31, 2023$270.00M+13.4%
Q4 FY2022Dec 31, 2022$271.00M–
Q3 FY2022Sep 30, 2022$260.00M–
Q2 FY2022Jun 30, 2022$257.00M–
Q1 FY2022Mar 31, 2022$238.00M–

More GE HealthCare Technologies figures

See a number that looks wrong?